English Blogactiv Posts - EU Blog Platform

Archives for Health & Consumers

We are awash with regulation. Healthcare and medicines are particularly affected. For instance, in their wisdom, European lawmakers have deemed it inappropriate for medicines to be advertised. And this in the 21st century, with open information access, calls for transparency and the empowered and informed patient. Of course, the logic of such restrictions reflect real-world… » read more

Green Week has come and gone for another year, and the most remarkable thing is that nobody noticed. This year I felt some sympathy for the event and the Commissioner for DG Environment, Janez Potočnik, who rightly described how we consider air quality issues as “hypocritical”. var addthis_config = {“data_track_clickback”:false,”data_track_addressbar”:false,”data_track_textcopy”:false,”ui_atversion”:”300″}; var addthis_product = ‘wpp-3.0.5’;

The Report on Clinical Trials agreed yesterday in the ENVI Committee would bring more transparency than before, but less than was originally proposed by the Rapporteur, Glenis Wilmott. She had proposed the publication of a Clinical Study Report within one year of the completion or termination of a trial. The compromise agreed a two stage… » read more

With its Contract for a Healthy Future, the medical technology industry acknowledges its role and responsibility in maintaining high-quality, affordable healthcare in Europe despite an ageing population and constrained budgets. This industry commitment offers the much needed solutions to prove that innovation is not a cost driver but a facilitator for driving healthcare quality and… » read more

Being a patient myself, I am keenly aware of the importance of having access to innovative technologies to support my lifestyle and foster improved health and well-being.  And, as a former policymaker in both the UK and the EU, I also understand the enormous responsibility of the healthcare system in determining which of the newest… » read more

Until recently economic and regional integration in the post-Soviet countries to a large extent was only declarative. However, the initiative of going beyond the Customs Union (CU) to create Common Economic Space (CES) between Russia, Belarus and Kazakhstan draws attention to potential market opportunities and at the same time regulatory challenges for the MedTech industry.  … » read more

EurActiv Network